Ayşegül Güler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayşegül Güler has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Muharrem Özkaya
Department of Thoracic Surgery, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey
3 shared publications - Nilay Çavuşoğlu Yalçın
Department of Thoracic Surgery, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey
3 shared publications - Arif Hakan Önder
Department of Medical Oncology, Antalya Training and Research Hospital, University of Health Sciences, 07100 Antalya, Türkiye
1 shared publication - Halil Göksel Güzel
Antalya Şehir Hastanesi
1 shared publication - Okan Karataş
Antalya Training and Research Hospital
1 shared publication
Latest Publications
- Open Access
- 18 May 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Educational quality of YouTube videos on robot-assisted thymectomy: a LAP-VEGaS-based evaluation
Video-based learning has become an integral component of surgical training, especially with the growing implementation of minimally invasive techniques suc
- 18 May 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessEducational quality of YouTube videos on robot-assisted thymectomy: a LAP-VEGaS-based evaluation
Video-based learning has become an integral component of surgical training, especially with the growing implementation of minimally invasive techniques suc
- Open Access
- 13 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 39869
Educational quality of YouTube videos on video assisted thoracoscopic segmentectomy
Video-assisted thoracoscopic segmentectomy (VATS) is increasingly performed as a parenchyma-sparing procedure for early-stage lung cancer, yet standardized educational resources remain limited. YouTube is widely accessed by surgeons and trainees, but the educational quality of its content is largely unregulated. This study systematically evaluated YouTube videos on VATS segmentectomy using the validated LAParoscopic surgery Video Educational GuidelineS (LAP-VEGaS) tool. A structured search was performed on June 12, 2025, and 34 videos with ≥ 2500 views were included. Two experienced thoracic surgeons independently assessed all videos, and inter-rater agreement was measured using Cohen’s kappa. The mean LAP-VEGaS score was 6.6 (range 2–14), with only 23.5% of videos reaching the validated threshold (≥ 11) for adequate educational quality. No significant correlation was observed between LAP-VEGaS scores and popularity metrics such as views, likes, or duration, although narration was strongly associated with higher scores. To our knowledge, this is the first study systematically evaluating VATS segmentectomy videos on YouTube using LAP-VEGaS. These findings demonstrate that most YouTube videos on VATS segmentectomy are educationally inadequate and highlight the need for peer-reviewed, curated repositories to ensure reliable and high-quality training materials for thoracic surgical education.
- 13 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 39869
Open AccessEducational quality of YouTube videos on video assisted thoracoscopic segmentectomy
Video-assisted thoracoscopic segmentectomy (VATS) is increasingly performed as a parenchyma-sparing procedure for early-stage lung cancer, yet standardized educational resources remain limited. YouTube is widely accessed by surgeons and trainees, but the educational quality of its content is largely unregulated. This study systematically evaluated YouTube videos on VATS segmentectomy using the validated LAParoscopic surgery Video Educational GuidelineS (LAP-VEGaS) tool. A structured search was performed on June 12, 2025, and 34 videos with ≥ 2500 views were included. Two experienced thoracic surgeons independently assessed all videos, and inter-rater agreement was measured using Cohen’s kappa. The mean LAP-VEGaS score was 6.6 (range 2–14), with only 23.5% of videos reaching the validated threshold (≥ 11) for adequate educational quality. No significant correlation was observed between LAP-VEGaS scores and popularity metrics such as views, likes, or duration, although narration was strongly associated with higher scores. To our knowledge, this is the first study systematically evaluating VATS segmentectomy videos on YouTube using LAP-VEGaS. These findings demonstrate that most YouTube videos on VATS segmentectomy are educationally inadequate and highlight the need for peer-reviewed, curated repositories to ensure reliable and high-quality training materials for thoracic surgical education.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (12) , e20250540
Global awareness and integration of immunotherapy among thoracic surgeons: a multicenter survey study
SUMMARY OBJECTIVE: Lung cancer is the leading cause of cancer-related mortality, with non-small cell lung cancer accounting for most cases. Surgery remains the primary treatment for early-stage non-small cell lung cancer, while advanced disease requires multimodal strategies. Immunotherapy, particularly immune checkpoint inhibitors targeting programmed cell death protein-1, programmed death-ligand 1, and cytotoxic T-lymphocyte-associated protein 4, has significantly improved survival and is increasingly incorporated into neoadjuvant and adjuvant settings. The aim of the study was to evaluate thoracic surgeons’ awareness, perceptions, and integration of immunotherapy in surgical practice. METHODS: A cross-sectional survey was conducted among 64 thoracic surgeons from 19 countries to assess their perspectives, challenges, and regional disparities in immunotherapy adoption. Statistical analyses examined associations between perceptions and variables such as specialty, experience, hospital type, and geographic region. RESULTS: Perceptions of immunotherapy did not differ significantly by specialty, experience, hospital type, or geographic location. However, significant associations were observed between years of experience and hospital type, as well as surgical specialty and geographic region. Key barriers included cost, lack of standardized guidelines, and challenges in multidisciplinary coordination. Surgeons in low- and middle-income countries reported greater difficulties in drug access and institutional infrastructure. The majority of participants (85%) expressed a need for further training, highlighting the importance of structured education programs and enhanced collaboration between surgical and medical oncology teams. CONCLUSION: While immunotherapy is widely accepted among thoracic surgeons, challenges related to education, accessibility, and implementation persist. Addressing these barriers through global initiatives, cost-effective policies, and multidisciplinary cooperation is essential for optimizing immunotherapy integration in thoracic surgery and improving outcomes for non-small cell lung cancer patients.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (12) , e20250540
Open AccessGlobal awareness and integration of immunotherapy among thoracic surgeons: a multicenter survey study
SUMMARY OBJECTIVE: Lung cancer is the leading cause of cancer-related mortality, with non-small cell lung cancer accounting for most cases. Surgery remains the primary treatment for early-stage non-small cell lung cancer, while advanced disease requires multimodal strategies. Immunotherapy, particularly immune checkpoint inhibitors targeting programmed cell death protein-1, programmed death-ligand 1, and cytotoxic T-lymphocyte-associated protein 4, has significantly improved survival and is increasingly incorporated into neoadjuvant and adjuvant settings. The aim of the study was to evaluate thoracic surgeons’ awareness, perceptions, and integration of immunotherapy in surgical practice. METHODS: A cross-sectional survey was conducted among 64 thoracic surgeons from 19 countries to assess their perspectives, challenges, and regional disparities in immunotherapy adoption. Statistical analyses examined associations between perceptions and variables such as specialty, experience, hospital type, and geographic region. RESULTS: Perceptions of immunotherapy did not differ significantly by specialty, experience, hospital type, or geographic location. However, significant associations were observed between years of experience and hospital type, as well as surgical specialty and geographic region. Key barriers included cost, lack of standardized guidelines, and challenges in multidisciplinary coordination. Surgeons in low- and middle-income countries reported greater difficulties in drug access and institutional infrastructure. The majority of participants (85%) expressed a need for further training, highlighting the importance of structured education programs and enhanced collaboration between surgical and medical oncology teams. CONCLUSION: While immunotherapy is widely accepted among thoracic surgeons, challenges related to education, accessibility, and implementation persist. Addressing these barriers through global initiatives, cost-effective policies, and multidisciplinary cooperation is essential for optimizing immunotherapy integration in thoracic surgery and improving outcomes for non-small cell lung cancer patients.